Pointellis™
Pointellis™ is an open, trusted data exchange platform and suite of applications that links all the key players in the cell and gene therapy (CGT) ecosystem involved in the patient’s treatment journey.
Your business challenge
Cell and gene therapies (CGTs) are ushering in a transformative era in medicine, and the number of patients treated with them is expected to grow from the hundreds today to hundreds of thousands by the decade’s end. But these life-changing therapies are complex and expensive to manufacture and administer. How can they be made available at scale for all those in need?
- Unlike chemotherapy, CGT development and service rely on multiple digital handoffs of time-sensitive information and materials across a diverse set of organizations and systems.
- Today, 90% of CGT treatments are not provided at the scheduled time.
- If every biopharma company built its own infrastructure to deliver these treatments it would cost an additional unnecessary US $1 billion.
- It currently takes six to eight weeks to treat a patient, leaving critically ill patients vulnerable.
To successfully scale CGTs, real-time signaling across an extraordinarily complex value chain will be essential, so that problems can be detected early and speedy course corrections made.
All members of the value chain must be able to securely communicate and share information they trust.
Solution benefits
Connecting each participant in the CGT value chain and forming a participatory information exchange, Pointellis™ speeds delivery of life-changing therapies, minimizes costly errors and makes these treatments more widely available. Pointellis™:
- Helps secure sharing of trusted information
- Provides earlier access to alerts and problems that could happen along the way and gives users the information to solve them
- Reduces system duplications that can be costly
- Frees up the CGT ecosystem to develop and deliver much needed therapies and helps to keep health care providers informed and engaged
Use case
As the various stakeholders in the CGT ecosystem move into the commercialization of their therapies, Pointellis™ will facilitate a more open and secure sharing of the required data and information.
Case study
Solution features & functionality
The EY organization teamed with Microsoft to develop Pointellis™, a trusted and secure data exchange platform and suite of applications to help biopharma companies scale-up their manufacturing and service of (individualized) cell and gene therapies for patients with cancers and inherited genetic disorders.
The platform brings together data from the diverse stakeholders of the CGT community in a participatory information exchange, simplifying access to information for the different steps of a patient’s personalized treatment.
There are many digital handoffs of data and information between all of the stakeholders within the CGT ecosystem to help determine the service of the right treatment, to the right patient, in the right place. Pointellis™ recognizes the need to provide a common set of data, made available through digital ID decoding, and easily shared in a secure and trusted environment.
As part of the Pointellis™ platform we have built a suite of applications aimed at resolving specific challenges within the industry by turning those data connections into actionable information.
The Case Assist tool, addresses the critical needs of the biopharma case worker by providing access to information that is traditionally found across several systems through a mobile application, thus eliminating manual searches and enabling better insight into a patient’s treatment journey status, in near-real time.
The Slot Schedule tool bridges the gap between manufacturing teams and health providers, allowing the capacity to manufacture treatments to be communicated at a glance - improving transparency for all users and helping to ensure available slots get filled.
The Logistics Organize tool allows logistics managers to have access to real-time shipment information at their fingertips by documenting and tracking shipments, monitoring temperature status and seeing all delivery routes — at a glance.
Why EY
Pointellis™, and its associated applications, facilitates the open, secure and transparent sharing of information among all the stakeholders in the treatment journey by allowing them to share information (from multiple digital sources) in a trusted environment. Pointellis™ creates a more participatory information exchange environment that will help with the continued growth and success of the CGT industry as it moves to greater levels of commercialization.
The team
Our latest thinking
Contact us
Like what you’ve seen? Get in touch to learn more.
